Mechanistic Insights from REDUCE-IT STRENGTHen the Case Against Triglyceride Lowering as a Strategy for Cardiovascular Disease Risk Reduction

Emerging Mechanisms of Cardiovascular Protection for the Omega-3 Fatty Acid Eicosapentaenoic Acid

(2020) R. Preston Mason et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Effect of icosapent ethyl on progression of coronary atherosclerosis in patients with elevated triglycerides on statin therapy: final results of the EVAPORATE trial

(2020) Matthew J Budoff et al.   EUROPEAN HEART JOURNAL

Mineral oil: safety and use as placebo in REDUCE-IT and other clinical studies

(2020) Brian Olshansky et al.   EUROPEAN HEART JOURNAL SUPPLEMENTS

Effects of Omega-3 Fatty Acids on Major Adverse Cardiovascular Events

(2020) Garima Sharma et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Effect of High-Dose Omega-3 Fatty Acids vs Corn Oil on Major Adverse Cardiovascular Events in Patients at High Cardiovascular Risk

(2020) Stephen J. Nicholls et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

New Insights into Mechanisms of Action for Omega-3 Fatty Acids in Atherothrombotic Cardiovascular Disease

(2019) R. Preston Mason   Current Atherosclerosis Reports

Coronary Artery Plaque Characteristics Associated With Adverse Outcomes in the SCOT-HEART Study

(2019) Michelle C. Williams et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Effects of Icosapent Ethyl on Total Ischemic Events: From REDUCE-IT

(2019) Deepak L. Bhatt et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Association of Triglyceride-Lowering LPL Variants and LDL-C–Lowering LDLR Variants With Risk of Coronary Heart Disease

(2019) Brian A. Ference et al.   JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION

Targeting RNA to lower triglycerides: long strides from short molecules

(2019) Arman Qamar et al.   EUROPEAN HEART JOURNAL

Comparison of mineral oil and non-mineral oil placebo on coronary plaque progression by coronary computed tomography angiography

(2019) Suvasini Lakshmanan et al.   CARDIOVASCULAR RESEARCH

Eicosapentaenoic acid improves endothelial function and nitric oxide bioavailability in a manner that is enhanced in combination with a statin

(2018) R. Preston Mason et al.   BIOMEDICINE & PHARMACOTHERAPY

Unmet Need for Adjunctive Dyslipidemia Therapy in Hypertriglyceridemia Management

(2018) Om P. Ganda et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Associations of Omega-3 Fatty Acid Supplement Use With Cardiovascular Disease Risks

(2018) Theingi Aung et al.   JAMA Cardiology

Effects of n−3 Fatty Acid Supplements in Diabetes Mellitus

(2018)   NEW ENGLAND JOURNAL OF MEDICINE

Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study

(2018) Aruna D. Pradhan et al.   AMERICAN HEART JOURNAL

Marine n−3 Fatty Acids and Prevention of Cardiovascular Disease and Cancer

(2018) JoAnn E. Manson et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cardiovascular Risk Reduction with Icosapent Ethyl for Hypertriglyceridemia

(2018) Deepak L. Bhatt et al.   NEW ENGLAND JOURNAL OF MEDICINE

A randomized controlled trial of eicosapentaenoic acid in patients with coronary heart disease on statins

(2017) Tetsu Watanabe et al.   Journal of Cardiology

Icosapent ethyl (eicosapentaenoic acid ethyl ester): Effects on plasma apolipoprotein C-III levels in patients from the MARINE and ANCHOR studies

(2016) Christie M. Ballantyne et al.   Journal of Clinical Lipidology

Triglycerides on the rise: should we swap seats on the seesaw?

(2014) Peter Libby   EUROPEAN HEART JOURNAL

Effects of Extended-Release Niacin with Laropiprant in High-Risk Patients

(2014)   NEW ENGLAND JOURNAL OF MEDICINE

Icosapent Ethyl, a Pure Ethyl Ester of Eicosapentaenoic Acid: Effects on Circulating Markers of Inflammation from the MARINE and ANCHOR Studies

(2013) Harold E. Bays et al.   American Journal of Cardiovascular Drugs

Remnant Cholesterol as a Causal Risk Factor for Ischemic Heart Disease

(2012) Anette Varbo et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Niacin in Patients with Low HDL Cholesterol Levels Receiving Intensive Statin Therapy

(2011)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of Combination Lipid Therapy in Type 2 Diabetes Mellitus

(2010)   NEW ENGLAND JOURNAL OF MEDICINE

Effects of EPA on coronary artery disease in hypercholesterolemic patients with multiple risk factors: Sub-analysis of primary prevention cases from the Japan EPA Lipid Intervention Study (JELIS)

(2008) Yasushi Saito et al.   ATHEROSCLEROSIS